India's drug regulator has suspended the permission granted to manufacture and sell their new eye drops, PresVu, which ...
Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for ...
On September 4, the drug regulator had asked for an explanation from the company for the claims it made in the press following which the drug-maker also submitted its response.
The Drugs Controller General of India (DCGI) has suspended the approval granted to Mumbai-based Entod Pharmaceuticals for ...
Regulatory approval to Entod Pharma for PresVu, meant to treat presbyopia, was revoked as the firm marketed it as a ...
DCGI suspends Entod Pharma`s eye drop permission for presbyopia treatment due to unapproved claims. The company will ...
Taking serious note of Mumbai-based Entod Pharmaceuticals’ claims that it can help reduce dependency on reading glasses for ...
In response to the various alleged misleading claims made by Entod Pharma in respect to its Opthalmologic product, Drugs ...
Drugs Controller General of India, who heads CDSCO, says Entod pharma failed to reply satisfactorily to queries raised. Entod ...
Entod Pharmaceuticals denies making false claims about their new PresVu eye drops and plans to challenge the suspension by ...
The Drug Controller General of India (DCGI) has suspended the licence for the eyedrop meant to reduce the need for reading glasses in people with Presbyopia. The licence of eyedrop PresVu, ...